Searched for
CSIR IGIB
Cellogen to bring next-gen cancer therapy to India"Chimeric Antigen Receptor cells represent a cutting-edge technology that holds great promise for cancer treatment. We are delighted to off...- Covid-19: Three months on, no unusual spike in Delta+ pockets in MaharashtraThe detection of 21 cases of the AY.1 sub-lineage, called ‘Delta plus’, in June had stoked fears of increased transmission or even an early...
- CSIR, Tata MD partner to ramp up Covid testing capacity across tier 2, 3 towns and rural areasThe initiative will utilise CSIR's network of labs across India and help increase testing capacity in smaller locations in the country. The...
- COVID-19: Consortium of four Indian cities funded for enhanced genome surveillanceEstablished with support and seed funding from Rockefeller Foundation, the new effort will track the emergence of viral variants correlated...
- Delta variant counted for 60% of Delhi's COVID-19 cases in April, says studyThe Delta variant, B.1.617.2, is 50 per cent more transmissible than the Alpha variant, B1.117, first discovered in the UK, say researchers...
- Covishield, Covaxin effective against 'Indian strain' of coronavirus, study suggests"Initial positive neutralisation studies of B.1.617, with both post-Covaxin or Covishield sera, are correlatable with milder disease during...
- Seropositivity for COVID-19 found to be lesser in smokers, vegetarians: CSIR surveyThe study which was piloted by CSIR-Institute of Genomics and Integrative Biology (IGIB), Delhi said of the 10,427 individuals, 1,058 (10.1...
- Coronavirus: SpiceHealth, CSIR-IGIB launch genome sequencing lab at Delhi airport"We have started a pilot project with SpiceHealth here at the airport to find out if we can generate the 'sequence' in less than 48 hours a...
- Discovery of a virulent variant of the SARS-CoV-2 should jolt India into speeding up its genome sequencingVariations in gene sequences will keep happening as the virus spreads across the globe, says principal scientific adviser K VijayRaghavan. ...
- TataMD launches new test for COVID-19; ready with 10 lakh tests/month capacityThe company's test 'TataMD CHECK' has been developed in partnership with CSIR-IGIB (Council of Scientific and Industrial Research-Institute...
- Feluda test will soon be rolled out to test Covid-19: Harsh VardhanDeveloped by CSIR-IGIB, the paper strip test has been approved by the Drug Controller General of India (DCGI) for a commercial launch.
- Tata Group officially ventures into the medical devices with Tata Medical and DiagnosticsOfficially incorporated in July 2020, the company manufactures medical appliances and instruments and appliances for measuring, checking, t...
- DCGI approves commercial launch of Tata Group's low cost Covid-19 test 'Feluda'The Tata CRISPR test achieves accuracy levels of traditional RT-PCR tests with quicker turnaround time, less expensive equipment and better...
- CSIR submits 53 genome sequences of coronavirus to global body; to share 450 more by May 15CSIR's Institute of Genomics and Integrative Biology (IGIB), Delhi, Centre for Cellular and Molecular Biology (CCMB), Hyderabad and Institu...
- 'Feluda': Made-in-India paper-based strip for rapid, mass testing for Covid-19A completely indigenous scientific invention, 'Feluda' has been designed for mitigating the ongoing Covid-19 situation and to cater to mass...
- CSIR lab, TaTa Sons sign MoU for licensing for COVID-19 knowhowThe license shall include transfer of the knowledge for scaling up the KNOWHOW in the form of a kit that can be deployed for COVID-19 testi...
- Genome sequencing: A solution to India's problem of rare genetic diseasesA genome is a person’s complete set of DNA, including all genes with more than 3 billion DNA base pairs. Genome sequencing will lead to pre...
- CSIR authorises private path lab for genetic testsNew Delhi, March 9 (IANS) Hoping to use private pathology labs to reach out to people, the Council of Scientific and Industrial Research (C...
- Currency notes host pathogens that can cause diseases: CSIR & IGIB researchThe pathogens on the currency notes can lead to several skin diseases, fungal infections, respiratory disorders and even tuberculosis.
- Government moves to cut off pension of top scientistDoPT has recommended action against Samir K Brahmachari, former secretary, department of scientific and industrial research, under rule 9 o...
Load More
